Nobel Prize-winning mRNA technology, which saved millions of lives during the COVID-19 pandemic through vaccines, is now being redirected toward fighting cancer, cystic fibrosis, and other serious ...
Researchers reviewed laboratory, clinical, and real-world data on mRNA vaccines. They confirmed safety and effectiveness and ...
Inventage Lab, a drug delivery platform company, announced on July 6 that it will present its research results on mass ...
A comprehensive review of the billions of COVID-19 vaccine doses made with mRNA technology shows that these vaccines are safe and effective. Vaccine skepticism increased during the COVID-19 pandemic, ...
Treatments based on the same mRNA technology that delivered COVID-19 vaccines to market in record time are showing lasting benefit against the deadly skin cancer melanoma ...
A more effective vaccine technology may be on the horizon. In a new study in mice, researchers from the University of Copenhagen demonstrate that a simple addition to mRNA vaccines can significantly ...
A new kind of flu vaccine is moving a step closer to the U.S. market.
The mRNA vaccines approved to treat COVID-19 are safe and effective and show promise in treating other diseases including ...
Moderna (MRNA) climbed to $81.42, up 169% annually. Analysts set average target at $37 while insiders sold $6.1M worth of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results